Concentric Capital Strategies’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,850
Closed -$529K 427
2025
Q2
$529K Buy
+5,850
New +$462K 0.02% 246
2024
Q2
Sell
-11,177
Closed -$829K 420
2024
Q1
$829K Buy
+11,177
New +$828K 0.05% 251

Other funds holding ALAB

Concentric Capital Strategies's ALAB Position: Q3 2025 in Review

Concentric Capital Strategies sold out of Astera Labs (ALAB) in Q3 2025, closing a stake of 5,850 shares — an estimated $529K sold.

Concentric Capital Strategies first reported a position in ALAB in Q1 2024 and held it in 2 quarters. The position peaked at $829K in Q1 2024. 657 funds tracked by Wall St. Rank hold ALAB as of Q3 2025.

  • Concentric Capital Strategies reported no remaining Astera Labs position as of Q3 2025 after selling out during the quarter.
  • Concentric Capital Strategies sold 5,850 Astera Labs shares in Q3 2025, an estimated $529K.
  • Concentric Capital Strategies first reported a position in Astera Labs in Q1 2024 and held it in 2 quarters.
  • Concentric Capital Strategies's Astera Labs position peaked at $829K in Q1 2024.
  • 657 funds tracked by Wall St. Rank held Astera Labs as of Q3 2025.

Based on Concentric Capital Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.